SBC Medical Group
SBC
4 hedge funds and large institutions have $173K invested in SBC Medical Group in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
520% more capital invested
Capital invested by funds: $27.9K → $173K (+$145K)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
33% more funds holding
Funds holding: 3 → 4 (+1)
0.01% more ownership
Funds ownership: 0.02% → 0.03% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$140K |
| 2 |
Morgan Stanley
New York
|
+$6.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tuttle Capital Management
Riverside,
Connecticut
|
-$2.15K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $132K | +$140K | +20,529 | +640% |
|
|
SS
2
SBI Securities
Tokyo,
Japan
| $35.9K | +$44.1K | +6,462 | New |
|
|
3
Morgan Stanley
New York
| $5K | +$6.14K | +900 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $117 | – | – | – |
|
|
TCM
5
Tuttle Capital Management
Riverside,
Connecticut
| – | -$2.15K | -14,369 | Closed |
|
SBC Hedge Fund Activity: Q4 2024 in Review
4 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in SBC Medical Group (SBC) for Q4 2024, worth a combined $173K — up 520% from $27.9K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new SBC positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $140K. The largest seller was Tuttle Capital Management, exiting entirely with an estimated $2.15K sold.
- 4 institutional investors held SBC Medical Group (SBC) as of Q4 2024, up from 3 in Q3 2024.
- Funds reported $173K of SBC Medical Group stock for Q4 2024, up 520% quarter-over-quarter.
- 2 funds opened new SBC Medical Group positions in Q4 2024 and 1 closed out, a net change of +1 holder.
- The largest SBC Medical Group buyer in Q4 2024 was UBS Group, an estimated $140K added.
- The largest SBC Medical Group seller in Q4 2024 was Tuttle Capital Management, an estimated $2.15K sold.
Based on aggregated 13F filings for Q4 2024.